SCHEMBL29570519

SCHEMBL29570519

NC(=O)C1(C(=O)c2ccc(F)cc2)CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.45
CES1 P23141 1/20 0.45
CA1 P00915 3/20 0.42
CA2 P00918 3/20 0.42
BCL2L1 Q07817 1/20 0.39
BAD Q92934 1/20 0.39
CA12 O43570 1/20 0.39
CA7 P43166 1/20 0.39
CA9 Q16790 1/20 0.39
CA14 Q9ULX7 1/20 0.39
MAOA P21397 1/20 0.39
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
KCNN4 O15554 1/20 0.38
PTPN1 P18031 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HTR1A P08908 1/20 0.37
ADRA2A P08913 1/20 0.37
DRD1 P21728 1/20 0.37
SLC6A4 P31645 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4385239 0.82 CES2 (0.46) CES2CES1CA1CA2BCL2L1
SCHEMBL29723507 0.76 CES2 (0.48) CES2CES1CA1CA2BCL2L1
SCHEMBL10524449 0.74 CES2 (0.50) CES2CES1CA1CA2BCL2L1
SCHEMBL29779489 0.73 CES2 (0.45) CES2CES1CA1CA2BCL2L1
SCHEMBL29779471 0.73 CES2 (0.45) CES2CES1CA1CA2BCL2L1
SCHEMBL2637159 0.73 TSHR (0.45) CES2CES1ALDH1A1
SCHEMBL28959012 0.73 CES2 (0.45) CES2CES1CA1CA2BCL2L1
SCHEMBL407809 0.73 ALDH1A1 (0.56) ALDH1A1
SCHEMBL10524470 0.72 CES2 (0.48) CES2CES1CA1CA2BCL2L1
SCHEMBL4266410 0.72 ALDH1A1 (0.44) CES2CES1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116802181-A Triazolopyridine compounds as kinase inhibitors 百时美施贵宝公司 2023-09-22 CN disclosed
EP-4229056-A1 TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS Bristol-Myers Squibb Company (US) 2023-08-23 EP disclosed
WO-2022086828-A1 TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2022-04-28 WO disclosed